Drugs / AZD9838
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06147063 | Nov 2023 → Apr 2024 | COVID-19 | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD9838 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06147063 ↗ |
| Modality | Vaccine | “AZD9838 and AZD6563 Vaccine” NCT06147063 ↗ |